Clinical Trial Update: A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine [Phase 1]

View source ↗

Summary

A phase 1 pharmacokinetic study evaluated L-697,661 alone and in combination with zidovudine in HIV infections. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• L-697,661
• Zidovudine (Zidovudine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Phase 1 | Status: COMPLETED